Roche Articles
Stock Commentary - New York week to April 21, 2008
28 April 2008
Stock Commentary - Europe - week to April 21, 2008
28 April 2008
Japan stock market week to Aril 21, 2008
28 April 2008
Roche's Avastin fails to show overall survival
28 April 2008
Generic firm accused of false promotion
28 April 2008
Abbott reports 35% rise in earnings
28 April 2008
FDA starts safety review of Roche's CellCept and Novartis' Myfortic after cases of PML
21 April 2008
Roche's Chugai wins approval for Actemra in Japan
21 April 2008
Stock Commentary - Europe - week to April 14, 2008
21 April 2008
Rapid test for fake Tamiflu detection
21 April 2008
Roche to appeal US Mircera sales bar
21 April 2008
Roche expands availability of HCV immunoassay
14 April 2008
Stock Commentary - Europe - week to April 7, 2008
14 April 2008
Chinese man contracts bird flu from son
14 April 2008
Medical care guidelines challenged in Japan
7 April 2008
India NGOs at war with cancer drug patents
7 April 2008
Stock Commentary - Europe - week to Mach 31, 2008
7 April 2008
Wyeth milestone for ArQule on AD drug
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
58.5% of Actemra patients achieve ACR20
31 March 2008
US MDs do not Rx to HLD guidelines
31 March 2008
Delay to EU approval of GSK
31 March 2008
Two senior appointments at Illumina
24 March 2008
Stock Commentary - Europe - week to March 17, 2008
24 March 2008
Japan stock market week to March 17, 2008
24 March 2008
Transgene's 2007 net loss narrows to $8.4M
24 March 2008
Stock Commentary - Europe - week to March 10, 2008
17 March 2008
Abbott and Genentech sign Tarceva assay deal
17 March 2008
Avastin to become new standard for HER2 MBC
17 March 2008
Japan stock market week to March 10, 2008
17 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
Roche's new CEO commits to p-med
10 March 2008
Strong early data on Davanat plus 5-FU in CRC
10 March 2008
Everolimus trial halted after early PFS gains
10 March 2008
LEEM marks first European Rare Diseases Day
10 March 2008
Stock Commentary - Europe - week to Feb 25, 2008
3 March 2008
Mixed Ph II data on AstraZeneca's Recentin
3 March 2008
Roche faces Xenical diet clinic probe
3 March 2008
Japan stock market week to Feb 25, 2008
3 March 2008
Mixed Ph II data on AstraZeneca's Recentin
3 March 2008
UK's NHS denies care to top-up patients
3 March 2008
Foreign groups try to stop Thailand CL climbdown
3 March 2008
Memory/Roche's MEM 3454 enters schizophrenia biomarker study
25 February 2008
Tokyo stocks in the week to February 18, 2008
25 February 2008
Roche completes Ventana acquisition
25 February 2008
Avastin improves PFS in breast cancer
25 February 2008
DSM's 4th-qtr profits up 2%; short of forecasts
25 February 2008
Fujifilm buying Toyama for up to $1.46B
25 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
ArQule's 4th-qtr 2007 loss widens to $14.4M
18 February 2008
UK's NICE asked to develop new clinical health guidance for DoH
18 February 2008
Thailand Health Ministry change could mean fewer CLs
18 February 2008
UK obesity drug Rxs pass million, increasing eightfold over 1999
14 February 2008
Japan stock market week to February 4 , 2008
14 February 2008
CuraGen's 4th qtr loss falls 22%; price too low
14 February 2008
Roche's Xeloda gets EC OK for bowel cancer
14 February 2008
Plethora's PSD506 shows promise in OB and UUI
11 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
EC grants Xeloda broad approval for mCRC
11 February 2008
Japan drug approval recommendations
11 February 2008
Roche pipeline includes several potential blockbusters likely to enter Ph III testing
11 February 2008
Tamiflu resistance seen in flu viruses, says ECDC
11 February 2008
Stock Commentary - Europe - week to Jan 28, 2008
4 February 2008
Stock Commentary - New York week to Jan 28, 2008
4 February 2008
EC broadens Avastin use in mCRC indication
4 February 2008
Patients on rituximab achieve ACR 20 response
4 February 2008
Roche's rituximab boosts PFS in CLL
4 February 2008
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
Kosan opens Ph II study of alvespimycin
28 January 2008
Roche's Avastin launched in UK for RCC
28 January 2008
Roche finally succeeds in Ventana bid
28 January 2008
Roche invests $389M in Germany, Switzerland
28 January 2008
FDA clears APP's Polmyxin B Sulfate
21 January 2008
Roche appoints Steven Sembler as VP of commercial operations
21 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
India patent battle over Tarceva opens new CL front
21 January 2008
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
